Logo image of A

AGILENT TECHNOLOGIES INC (A) Stock Fundamental Analysis

USA - NYSE:A - US00846U1016 - Common Stock

146.74 USD
-0.75 (-0.51%)
Last: 11/7/2025, 8:04:00 PM
146.74 USD
0 (0%)
After Hours: 11/7/2025, 8:04:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to A. A was compared to 58 industry peers in the Life Sciences Tools & Services industry. While A belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. A is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year A was profitable.
A had a positive operating cash flow in the past year.
Each year in the past 5 years A has been profitable.
In the past 5 years A always reported a positive cash flow from operatings.
A Yearly Net Income VS EBIT VS OCF VS FCFA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

A has a better Return On Assets (9.98%) than 89.66% of its industry peers.
With an excellent Return On Equity value of 19.15%, A belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.99%, A belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for A is in line with the industry average of 13.50%.
Industry RankSector Rank
ROA 9.98%
ROE 19.15%
ROIC 12.99%
ROA(3y)11.44%
ROA(5y)10.62%
ROE(3y)22.24%
ROE(5y)20.78%
ROIC(3y)14.65%
ROIC(5y)13.29%
A Yearly ROA, ROE, ROICA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 17.97%, A belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
In the last couple of years the Profit Margin of A has remained more or less at the same level.
A's Operating Margin of 22.44% is amongst the best of the industry. A outperforms 93.10% of its industry peers.
In the last couple of years the Operating Margin of A has grown nicely.
The Gross Margin of A (52.92%) is better than 62.07% of its industry peers.
In the last couple of years the Gross Margin of A has remained more or less at the same level.
Industry RankSector Rank
OM 22.44%
PM (TTM) 17.97%
GM 52.92%
OM growth 3Y4.07%
OM growth 5Y5.41%
PM growth 3Y1.12%
PM growth 5Y-0.93%
GM growth 3Y0.36%
GM growth 5Y0.01%
A Yearly Profit, Operating, Gross MarginsA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so A is still creating some value.
Compared to 1 year ago, A has less shares outstanding
A has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, A has a worse debt to assets ratio.
A Yearly Shares OutstandingA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
A Yearly Total Debt VS Total AssetsA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

A has an Altman-Z score of 5.61. This indicates that A is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of A (5.61) is better than 84.48% of its industry peers.
A has a debt to FCF ratio of 3.13. This is a good value and a sign of high solvency as A would need 3.13 years to pay back of all of its debts.
A's Debt to FCF ratio of 3.13 is fine compared to the rest of the industry. A outperforms 79.31% of its industry peers.
A has a Debt/Equity ratio of 0.54. This is a neutral value indicating A is somewhat dependend on debt financing.
A has a Debt to Equity ratio of 0.54. This is in the lower half of the industry: A underperforms 63.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 3.13
Altman-Z 5.61
ROIC/WACC1.26
WACC10.33%
A Yearly LT Debt VS Equity VS FCFA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A has a Current Ratio of 2.25. This indicates that A is financially healthy and has no problem in meeting its short term obligations.
A has a Current ratio (2.25) which is comparable to the rest of the industry.
A Quick Ratio of 1.71 indicates that A should not have too much problems paying its short term obligations.
A has a Quick ratio (1.71) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.71
A Yearly Current Assets VS Current LiabilitesA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.61% over the past year.
A shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.14% yearly.
A shows a small growth in Revenue. In the last year, the Revenue has grown by 4.48%.
Measured over the past years, A shows a small growth in Revenue. The Revenue has been growing by 4.75% on average per year.
EPS 1Y (TTM)4.61%
EPS 3Y6.82%
EPS 5Y11.14%
EPS Q2Q%3.79%
Revenue 1Y (TTM)4.48%
Revenue growth 3Y1%
Revenue growth 5Y4.75%
Sales Q2Q%10.14%

3.2 Future

Based on estimates for the next years, A will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.99% on average per year.
The Revenue is expected to grow by 5.88% on average over the next years.
EPS Next Y7.48%
EPS Next 2Y7.68%
EPS Next 3Y8.51%
EPS Next 5Y8.99%
Revenue Next Year6.72%
Revenue Next 2Y6.09%
Revenue Next 3Y5.97%
Revenue Next 5Y5.88%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
A Yearly Revenue VS EstimatesA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
A Yearly EPS VS EstimatesA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.92 indicates a quite expensive valuation of A.
Based on the Price/Earnings ratio, A is valued a bit cheaper than the industry average as 77.59% of the companies are valued more expensively.
A is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.92, which indicates a rather expensive current valuation of A.
A's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. A is cheaper than 77.59% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of A to the average of the S&P500 Index (32.68), we can say A is valued slightly cheaper.
Industry RankSector Rank
PE 26.92
Fwd PE 23.92
A Price Earnings VS Forward Price EarningsA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of A indicates a somewhat cheap valuation: A is cheaper than 72.41% of the companies listed in the same industry.
63.79% of the companies in the same industry are more expensive than A, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 38.24
EV/EBITDA 24.12
A Per share dataA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates A does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of A may justify a higher PE ratio.
PEG (NY)3.6
PEG (5Y)2.42
EPS Next 2Y7.68%
EPS Next 3Y8.51%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.69%, A is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.50, A pays a better dividend. On top of this A pays more dividend than 98.28% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, A's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.69%

5.2 History

On average, the dividend of A grows each year by 7.63%, which is quite nice.
A has paid a dividend for at least 10 years, which is a reliable track record.
A has decreased its dividend recently.
Dividend Growth(5Y)7.63%
Div Incr Years1
Div Non Decr Years1
A Yearly Dividends per shareA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

22.95% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
The dividend of A is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP22.95%
EPS Next 2Y7.68%
EPS Next 3Y8.51%
A Yearly Income VS Free CF VS DividendA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
A Dividend Payout.A Dividend Payout, showing the Payout Ratio.A Dividend Payout.PayoutRetained Earnings

AGILENT TECHNOLOGIES INC

NYSE:A (11/7/2025, 8:04:00 PM)

After market: 146.74 0 (0%)

146.74

-0.75 (-0.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners92.27%
Inst Owner Change-0.99%
Ins Owners0.13%
Ins Owner Change0.03%
Market Cap41.60B
Revenue(TTM)6.79B
Net Income(TTM)1.22B
Analysts75.38
Price Target152.19 (3.71%)
Short Float %1.2%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield 0.69%
Yearly Dividend0.95
Dividend Growth(5Y)7.63%
DP22.95%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-30 2025-09-30 (0.248)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.04%
Min EPS beat(2)-1.64%
Max EPS beat(2)1.56%
EPS beat(4)3
Avg EPS beat(4)0.66%
Min EPS beat(4)-1.64%
Max EPS beat(4)1.57%
EPS beat(8)7
Avg EPS beat(8)1.26%
EPS beat(12)10
Avg EPS beat(12)1.89%
EPS beat(16)13
Avg EPS beat(16)2.06%
Revenue beat(2)2
Avg Revenue beat(2)1.42%
Min Revenue beat(2)0.54%
Max Revenue beat(2)2.3%
Revenue beat(4)2
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)2.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.06%
Revenue beat(12)6
Avg Revenue beat(12)0.29%
Revenue beat(16)7
Avg Revenue beat(16)0.09%
PT rev (1m)11.32%
PT rev (3m)11.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.87%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.89%
Valuation
Industry RankSector Rank
PE 26.92
Fwd PE 23.92
P/S 6.13
P/FCF 38.24
P/OCF 27.83
P/B 6.53
P/tB 29.17
EV/EBITDA 24.12
EPS(TTM)5.45
EY3.71%
EPS(NY)6.13
Fwd EY4.18%
FCF(TTM)3.84
FCFY2.62%
OCF(TTM)5.27
OCFY3.59%
SpS23.94
BVpS22.47
TBVpS5.03
PEG (NY)3.6
PEG (5Y)2.42
Graham Number52.49
Profitability
Industry RankSector Rank
ROA 9.98%
ROE 19.15%
ROCE 14.74%
ROIC 12.99%
ROICexc 15.25%
ROICexgc 34.51%
OM 22.44%
PM (TTM) 17.97%
GM 52.92%
FCFM 16.03%
ROA(3y)11.44%
ROA(5y)10.62%
ROE(3y)22.24%
ROE(5y)20.78%
ROIC(3y)14.65%
ROIC(5y)13.29%
ROICexc(3y)17.07%
ROICexc(5y)15.7%
ROICexgc(3y)42.54%
ROICexgc(5y)41.66%
ROCE(3y)16.57%
ROCE(5y)15.04%
ROICexgc growth 3Y-7.71%
ROICexgc growth 5Y-3.01%
ROICexc growth 3Y-0.19%
ROICexc growth 5Y4.58%
OM growth 3Y4.07%
OM growth 5Y5.41%
PM growth 3Y1.12%
PM growth 5Y-0.93%
GM growth 3Y0.36%
GM growth 5Y0.01%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 3.13
Debt/EBITDA 1.88
Cap/Depr 142.31%
Cap/Sales 6%
Interest Coverage 17.92
Cash Conversion 82.64%
Profit Quality 89.18%
Current Ratio 2.25
Quick Ratio 1.71
Altman-Z 5.61
F-Score5
WACC10.33%
ROIC/WACC1.26
Cap/Depr(3y)116.28%
Cap/Depr(5y)89.27%
Cap/Sales(3y)4.81%
Cap/Sales(5y)3.93%
Profit Quality(3y)102.27%
Profit Quality(5y)105.09%
High Growth Momentum
Growth
EPS 1Y (TTM)4.61%
EPS 3Y6.82%
EPS 5Y11.14%
EPS Q2Q%3.79%
EPS Next Y7.48%
EPS Next 2Y7.68%
EPS Next 3Y8.51%
EPS Next 5Y8.99%
Revenue 1Y (TTM)4.48%
Revenue growth 3Y1%
Revenue growth 5Y4.75%
Sales Q2Q%10.14%
Revenue Next Year6.72%
Revenue Next 2Y6.09%
Revenue Next 3Y5.97%
Revenue Next 5Y5.88%
EBIT growth 1Y-5.11%
EBIT growth 3Y5.1%
EBIT growth 5Y10.42%
EBIT Next Year19.73%
EBIT Next 3Y11.85%
EBIT Next 5Y9.19%
FCF growth 1Y-23.38%
FCF growth 3Y1.94%
FCF growth 5Y9.68%
OCF growth 1Y-12.27%
OCF growth 3Y5.65%
OCF growth 5Y11.39%

AGILENT TECHNOLOGIES INC / A FAQ

Can you provide the ChartMill fundamental rating for AGILENT TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to A.


What is the valuation status of AGILENT TECHNOLOGIES INC (A) stock?

ChartMill assigns a valuation rating of 4 / 10 to AGILENT TECHNOLOGIES INC (A). This can be considered as Fairly Valued.


Can you provide the profitability details for AGILENT TECHNOLOGIES INC?

AGILENT TECHNOLOGIES INC (A) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for A stock?

The Price/Earnings (PE) ratio for AGILENT TECHNOLOGIES INC (A) is 26.92 and the Price/Book (PB) ratio is 6.53.


What is the financial health of AGILENT TECHNOLOGIES INC (A) stock?

The financial health rating of AGILENT TECHNOLOGIES INC (A) is 6 / 10.